ACR Journals On Air

American College of Rheumatology
undefined
May 28, 2024 • 36min

The RENEW Study in Scleroderma

Researchers discuss a study on self-management interventions for systemic sclerosis patients to improve fatigue. Topics include resilience-building energy management program, peer mentorship, coaching training, participant randomization, remote recruitment, outcomes of peer health coaching, and plans for program expansion.
undefined
May 14, 2024 • 48min

Is There an App for That?

Exploring the efficiency impact of mobile apps for rheumatoid arthritis care, featuring insights from Dr. Solomon. Empowering patients with Room App for symptom tracking. Study design, outcomes, and challenges of integrating mobile health app in rheumatologic care. Publication challenges and insights on becoming an editor in chief. Innovative initiatives in rheumatology journals to enhance reader engagement.
undefined
Apr 30, 2024 • 22min

Protecting Against Uveitis in Axial Spondyloarthritis (AxSpA)

Dr. Katie Bechman discusses protecting against Uveitis in AxSpA patients through her research findings. Topics include systematic review on treatment options, managing Uveitis, navigating manuscript writing during the pandemic, and career aspirations in rheumatology.
undefined
Apr 16, 2024 • 50min

History of Interferon (Immunology for the Rheumatologist)

Dr. Mary Crow, MD, co-author of an article on interferon research, discusses its history, impact on autoimmune diseases like lupus, connections to the AIDS epidemic, and potential therapeutic applications. She also highlights exceptional patient care and research focus at the Hospital for Special Surgery, reflecting on leadership in rheumatology and the importance of embracing failures in research.
undefined
Apr 2, 2024 • 25min

The Scleroderma Cancer Connection

Dr. Ami A Shah from Johns Hopkins discusses the link between Scleroderma and cancer risk, highlighting specific antibody profiles as indicators. The podcast explores genetic alterations, biomarkers, and collaborations in examining this connection. Dr. Shah also shares her journey to becoming a physician-scientist, mentoring others in Scleroderma research through a K24 grant, and emphasizing leadership and collaboration in the Rheumatology Division at Johns Hopkins.
undefined
Mar 19, 2024 • 21min

Gut Feelings

Explore the connection between gut nerves, intuition, and gut health through a study on Anti-Gephron Antibodies in systemic sclerosis. Discover how antibodies in the gastrointestinal tract impact gut function and potential biomarkers for lower GI disease. Hear about a rheumatologist's career journey and insights on transitioning to an independent investigator. Learn about the challenges and importance of a supportive network when moving institutions.
undefined
Mar 5, 2024 • 36min

B-Cells in Sjogren's Syndrome

Dr. Steinmetz discusses B cell hyperactivity in Sjogren's Syndrome, ASC maturity, salivary gland infiltration, and new technologies in antibody cell analysis. The podcast also explores the challenges in studying IgG levels, international research experiences, and the evolving nature of scientific knowledge.
undefined
Feb 20, 2024 • 49min

Global Perspective on COVID 19

Exploring the global impact of COVID-19 on rheumatic disease patients and healthcare providers worldwide. Discussion on challenges faced, responses in Australia and New Zealand, lessons learned from unique COVID-19 responses, and the impact on rheumatology patients globally. Reflections on volunteering for board of directors and the Fulbright program and cultural exchange.
undefined
Feb 6, 2024 • 33min

The Power of the Negative Study

Dr. David R. Jayne discusses his study on an anti-CD40 antibody in lupus nephritis, highlighting the power of negative studies. They talk about challenges in conducting trials, measurement of anti-drug antibodies, embracing failures in science, and the importance of publishing negative results.
undefined
Jan 23, 2024 • 33min

Bad for the Bones

Dr. Giovanni Adami, a researcher studying bone loss in patients treated with low-dose glucocorticoids, discusses the potential benefits of low doses in inflammatory diseases and the limitations of measuring bone mineral density in glucocorticoid-induced osteoporosis. The podcast also explores the findings of a study on osteoporosis therapy for rheumatic disease patients receiving lower glucocorticoid doses, suggesting a change in practice compared to current guidelines.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app